Connect with us
Client Portals
In 2026 the U.S. cannabis industry will grapple with evolving banking and payments challenges, lingering barriers to major bank access, and rising compliance demands. Federal changes may redefine “intoxicating hemp,” tightening which cannabinoids are legal. Licensed…
A recent Drug Testing Advisory Board meeting highlighted evidence suggesting hair drug testing may be more reliablethan urine testing for detecting illegal drug use, especially in trucking. Presenters noted hair tests offer a longerdetection window, are harder to…
Should employers continue drug testing for marijuana as legalization spreads across many U.S. states? Whilemarijuana remains federally illegal, changing state laws are prompting employers to reconsider testing policies,especially where off-duty use is protected. It…
A new scientific review concludes that marijuana’s restrictive federal classification as a Schedule I drug — implyinghigh danger and no accepted medical use — isn’t supported by current science. Researchers argue that marijuana andsome other substances are less…
Kentucky Governor Andy Beshear said he’s not satisfied with the slow rollout of the state’s medical marijuana programbut expects patient access to accelerate significantly in 2026. He noted the approval of the first cannabis processorand the recent opening of…
President Trump signed an executive order to speed up rescheduling marijuana to Schedule III, which benefits thecannabis industry but creates uncertainty for CDL drug testing. Current federal testing rules only cover Schedule I/IIdrugs, so marijuana might no longer be…
H.R. 5371, signed in November 2025, narrows the federal definition of hemp, banning intoxicating cannabinoids likedelta-8, delta-10, and THCA by capping total THC at 0.3% and prohibiting synthetic cannabinoids. Effective November2026, the law clarifies employer…
Texas is expanding its Compassionate Use Program, allowing more patients with conditions like chronic pain, traumatic brain injury, and serious illnesses to access low-THC medical cannabis. Phase one selected nine businesses for further evaluation, though final…
With marijuana legalized for medical or recreational use in most U.S. states, employers face a complex decision on drug testing. Testing can ensure legal compliance, workplace safety, and lower insurance costs, especially in regulated industries. However, tests often…
President Trump is considering rescheduling marijuana from Schedule I to Schedule III, which could remove DOT’s legal authority to test nearly 4 million CDL drivers, as DOT testing relies on HHS guidelines tied to Schedule I/II substances. Without a safety carve-out,…